ADC Therapeutics SA

The momentum for this stock is not very good. ADC Therapeutics SA has good growth characteristics. ADC Therapeutics SA is not very popular among insiders. Tradey thinks it is not wise to invest in ADC Therapeutics SA.

News

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Globe Newswire LAUSANNE, Switzerland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today...\n more…

ADC Therapeutics to Present at Upcoming Investor Conferences

ADC Therapeutics Insiders Forfeit On 10% Gains After Selling Stock

Simply Wall St Despite the fact that ADC Therapeutics SA (NYSE:ADCT) stock rose 10% last week, insiders who sold US$267k worth of...\n more…

ADC Therapeutics SA (NYSE:ADCT) Short Interest Down 6.0% in July

Zolmax ADC Therapeutics SA (NYSE:ADCT - Get Free Report) was the recipient of a significant drop in short interest during the month of July. As of July 31st, there was short interest totalling 3,000,000...\n more…

ADC Therapeutics SA (NYSE:ADCT) Sees Large Drop in Short Interest

Ticker Report ADC Therapeutics SA (NYSE:ADCT - Get Free Report) saw a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 3,000,000 shares, a drop of 6.0...\n more…

ADC Therapeutics SA 2024 Q2 - Results - Earnings Call Presentation

SeekingAlpha ADC Therapeutics SA 2024 Q2 - Results - Earnings Call Presentation...\n more…